John L. Higgins - Sep 15, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: Charles S. Berkman For: John L. Higgins
Stock symbol
LGND
Transactions as of
Sep 15, 2022
Transactions value $
-$448,050
Form type
4
Date filed
9/16/2022, 07:49 PM
Previous filing
Aug 12, 2022
Next filing
Sep 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale -$180K -2K -0.54% $90.00 367K Sep 15, 2022 Direct
transaction LGND Common Stock Sale -$268K -3K -0.82% $89.35 364K Sep 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $90.00, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.